Literature DB >> 19578537

Modulation of gene expression in Actinobacillus pleuropneumoniae exposed to bronchoalveolar fluid.

Abdul G Lone1, Vincent Deslandes, John H E Nash, Mario Jacques, Janet I Macinnes.   

Abstract

BACKGROUND: Actinobacillus pleuropneumoniae, the causative agent of porcine contagious pleuropneumonia, is an important pathogen of swine throughout the world. It must rapidly overcome the innate pulmonary immune defenses of the pig to cause disease. To better understand this process, the objective of this study was to identify genes that are differentially expressed in a medium that mimics the lung environment early in the infection process. METHODS AND PRINCIPAL
FINDINGS: Since bronchoalveolar lavage fluid (BALF) contains innate immune and other components found in the lungs, we examined gene expression of a virulent serovar 1 strain of A. pleuropneumoniae after a 30 min exposure to BALF, using DNA microarrays and real-time PCR. The functional classes of genes found to be up-regulated most often in BALF were those encoding proteins involved in energy metabolism, especially anaerobic metabolism, and in cell envelope, DNA, and protein biosynthesis. Transcription of a number of known virulence genes including apxIVA and the gene for SapF, a protein which is involved in resistance to antimicrobial peptides, was also up-regulated in BALF. Seventy-nine percent of the genes that were up-regulated in BALF encoded a known protein product, and of these, 44% had been reported to be either expressed in vivo and/or involved in virulence.
CONCLUSIONS: The results of this study suggest that in early stages of infection, A. pleuropneumoniae may modulate expression of genes involved in anaerobic energy generation and in the synthesis of proteins involved in cell wall biogenesis, as well as established virulence factors. Given that many of these genes are thought to be expressed in vivo or involved in virulence, incubation in BALF appears, at least partially, to simulate in vivo conditions and may provide a useful medium for the discovery of novel vaccine or therapeutic targets.

Entities:  

Mesh:

Year:  2009        PMID: 19578537      PMCID: PMC2700959          DOI: 10.1371/journal.pone.0006139

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Actinobacillus pleuropneumoniae is a species-specific swine pathogen that causes a necrotizing, fibrinohaemorrhagic pneumonia with pleurisy [1]. Depending upon the immune status of the animal, disease can range in severity from peracute to chronic [2], [3]. Although a protective immune response is usually acquired through the adaptive immune system following acute infection, vaccines offer only partial protection against this organism. The lungs, which are the primary site of infection by A. pleuropneumoniae, have a large surface area that is directly in contact with the external environment. There are no published data for swine, but in the human lung, there is an average of 480 million alveoli [4] with an area of 120 to 140 m2 [5]. The lungs are protected by both innate and adaptive immune systems. Two major components are involved in the innate immune system: a cellular component comprised of leukocytes as well as airway and alveolar epithelial cells, and a humoral component which includes surfactant lipids and proteins, collectins, defensins, cathelicidins, lysozyme, and lactoferrin [6]. Most of these innate immune components reside in a thin layer of fluid lining the lung epithelial cell layer and some have been shown to directly kill bacteria such as Escherichia coli and Pseudomonas aeruginosa [7]–[9]. Inhaled particles, including pathogens, first encounter the resident immune system in this fluid layer, which forms the first line of defense [10], [11]. Little work has been done to examine bacterial gene expression in BALF, but in a recent study Schwab et al. [12] found that Myobacterium tuberculosis genes encoding proteins which enabled the organism to use surfactant lipids as a substrate and those for synthesis of phthiolocerol dimycocerosate (PDIM), a protective cell wall component, were up-regulated in the presence of a whole lung surfactant preparation. A. pleuropneumoniae is capable of overcoming innate pulmonary immune mechanisms of the pig. It can rapidly multiply and spread in naive herds, with some pigs dying within 24 h of infection without showing any clinical signs. Several virulence factors have been described in A. pleuropneumoniae to explain its pathogenesis; factors for colonization, nutrient acquisition, immune evasion and tissue destruction have all been implicated in the disease process [13], [14]. Although some aspects of pathogenesis can be explained by the production of tissue-damaging RTX toxins and the ability of the pathogen to acquire nutrients such as iron in the host, factors involved in bacterial survival and rapid multiplication in the host are largely unknown. To identify genes that may be involved in survival and pathogenesis of A. pleuropneumoniae in the host we used porcine bronchoalveolar fluid as a medium to simulate, in part, the lung environment. By analogy with other species, BALF collected from swine likely contains plasma proteins and proteins with unknown functions [15] as well as proteins with diverse functions including anti-oxidation, lipid-metabolism, and tissue repair and proliferation in addition to innate immune components and dissolved minerals. Because BALF contains components that perform diverse functions in the lungs, A. pleuropneumoniae gene expression in this fluid could mimic gene expression in the host. Therefore, the objective of this study was to identify A. pleuropneumoniae genes that are differentially expressed in BALF to better understand survival and pathogenesis of this important swine pathogen early in the disease process.

Results and Discussion

Differential gene expression in BALF

The survival of A. pleuropneumoniae CM5 was assessed in BALF before carrying out experiments to identify differentially expressed genes since this fluid contains many antibacterial substances [6], [16]. No significant decrease was observed in A. pleuropneumoniae CM5 cell numbers following incubation for 30 min in BALF, while 70% of the E. coli DH5α cells were killed at this time. Genes that were differentially expressed by A. pleuropneumoniae after 30 min of incubation in BALF were identified with DNA microarrays by hybridization of Cy3-labeled cDNA from the BALF-incubated bacteria (target sample) and Cy5-labelled cDNA from the BHI-incubated bacteria (reference sample). One hundred and fifty-six genes were differentially expressed in BALF at a false discovery rate (FDR) of 1.07%; 52 genes were down-regulated while 104 were up-regulated. Forty-one (26%) of these genes encode hypothetical proteins (Table 1).
Table 1

Functional classes of differentially expressed genes.

Functional classNo. up-regulatedNo. down-regulatedTotal differentially expressed genes
Protein biosynthesis16117
Amino acid biosynthesis099
Cofactor biosynthesis (heme and vitamins)606
Nucleotide biosynthesis033
Lipid biosynthesis101
Cell envelope biosynthesis11011
Detoxification and toxin production516
DNA metabolism80
Energy metabolism22426
Protein folding and stabilization044
Transcriptional regulators033
Secretion and trafficking13518
Transposon functions033
Unclassified and unknowns221941
Total10452157
Differential expression of selected genes representing various biological functional classes of interest was confirmed by real-time PCR analysis. Although fold change in gene expression measured by real-time PCR was generally higher, there was a good correlation between the two data sets, and no genes that were deemed up-regulated with the microarrays were demonstrated to be down-regulated by qRT-PCR, and vice-versa (Table 2). The reason why the three nqr genes tested appeared to be overestimated in the microarray analysis is not clear, but these slightly divergent results were not likely due to dynamic range or % G+C considerations.
Table 2

Verification of microarray data by real-time PCR.

GeneGene nameFold change by real-time PCRFold change by microarray
dmsA Anaerobic dimethyl sulfoxide reductase chain A precursor17.90±6.525.74
dmsB Anaerobic dimethyl sulfoxide reductase chain B10.12±3.342.78
nqrB Na+-translocating NADH quinone reductase subunit B4.62±1.637.65
nqrC Na+-translocating NADH quinone reductase subunit C4.57±1.36.35
nqrE Na+-translocating NADH quinone reductase subunit E4.84±1.596.36
napB Nitrate reductase cytochrome ctype subunit11.61±3.944.69
napF Ferredoxin-type protein NapF15.94±5.356.42
napD Putative NapD protein18.59±7.253.93
apxIVA RTX toxin protein4.07±2.021.93
dapA Dihydrodipicolinate synthase0.09±0.020.20
leuC 3-isopropylmalate dehydratase large subunit 20.15±0.140.28
ilvH Acetolactate synthase small subunit0.13±0.170.27
The genes found to be most frequently up-regulated in BALF were those encoding proteins involved in energy metabolism and in cell envelope, DNA, and protein biosynthesis (Table S1). Genes encoding proteins for co-factor biosynthesis, toxin production and secretion and trafficking of ions and biomolecules were also up-regulated while genes encoding proteins involved in protein folding and stabilization, nucleotide biosynthesis, and mobile elements were down-regulated. Representative genes belonging to these functional classes are described below.

Modulation of gene expression for enhanced protein synthesis and energy generation in BALF

Incubation of A. pleuropneumoniae CM5 in BALF for 30 min resulted in increased expression of genes encoding 30S and 50S ribosomal subunit proteins and tRNA modification enzymes (Table S1). Such up-regulation of ribosomal genes could play a role in synthesis of the proteins described below. Genes encoding proteins involved in energy metabolism were also up-regulated in BALF, with some showing an increase of more than 6-fold. Most of these genes encoded enzymes involved in anaerobic respiration, including those that were part of the dimethyl sulfoxide reductase (dms) operon), periplasmic nitrate reductase (nap) operon, nitrite reductase (nrf) operon and a primary dehydrogenase, hydrogenase 2 (hya) operon (Table S1). Dimethyl sulfoxide (DMSO) reductase catalyzes the transfer of electrons to dimethyl sulfoxide and other substrates; the periplasmic-nitrate and nitrite reductases are involved in transfer of electrons to nitrate and nitrite respectively [17]. Hydrogenase 2, a primary dehydrogenase, uses the hydrogen produced by formate hydrogen lyase from formate as a substrate [18] for energy production [19], [20]. A putative formate transporter, focA, was also up-regulated in BALF. Previous studies have shown that A. pleuropneumoniae up-regulates transcription of genes encoding enzymes involved in anaerobic metabolism in porcine lungs and lung washings [21]–[23]. A. pleuropneumoniae recovered from BALF following infection have increased expression of hydrogenase 2 [21], aspartate ammonia lyase (Asp) [24] and DMSO reductase [25], with DMSO reductase levels being elevated in cells recovered from both acute and chronic infections [22], [23]. The components present in BALF that could lead to up-regulation of anaerobic energy-metabolism genes in A. pleuropneumoniae are largely unknown; however, glutathione in the airway epithelium might be an activator of HlyX, which is the A. pleuropneumoniae equivalent of FNR in E. coli [26]. For example, it has been reported HlyX up-regulates DMSO reductase (dms) and aspartate ammonia lyase (asp), which breaks down aspartate to fumarate and ammonia. Fumarate is used as an electron acceptor under anaerobic conditions in A. pleuropneumoniae [27]–[30]. The fact that a significant change of expression of hlyX was not observed may be because differences in the level of expression of this gene tend to be small. Moreover, like fnr, regulation of the hlyX gene product is likely affected by a multitude of factors including protein stability, growth phase and nutrient availability [31], [32]. Up-regulation of the genes encoding the periplasmic nitrate (Nap) reductase in BALF suggests a role for nitrate metabolism in A. pleuropneumoniae energy production in the host. Nap uses nitrate as an electron acceptor. As nitrate has a higher redox potential than most other electron acceptors under anaerobic conditions [17], [33] it is a preferred electron acceptor. Nitrate is formed from nitric oxide in the animal and is present in various body fluids [34]–[37] where it can serve as a cue for the up-regulation of nitrate-responsive genes in A. pleuropneumoniae. Nap has a higher affinity for nitrate than membrane-bound nitrate reductase (Nar) [38], and it can be used for nitrate utilization in body fluids with low nitrate concentrations such as are found in the respiratory tract. Nitrite reductase (Nrf) is another nitrate metabolism-related enzyme whose genes were up-regulated in BALF. This enzyme converts nitrite, a potential bacterial cell-damaging substance produced by nitrate reductase, to ammonia. Nrf can also convert nitric oxide to ammonium [39], thus inactivating a key defense molecule of the host. Given that A. pleuropneumoniae is a host-associated pathogen which resides in oxygen-deprived environments in both the acute and carrier states of the disease, the major production of energy is likely through anaerobic metabolism. The absence of three main TCA-cycle enzymes (citrate synthase, aconitase and isocitrate dehydrogenase) in the genomes of serotype 3 and serotype 5 A. pleuropneumoniae again points to the importance of anaerobic metabolism in the survival of this organism [40]. In addition, many upper respiratory tract pathogens including Haemophilus influenzae, Pseudomonas aeruginosa, Pasteurella multocida, Neisseria meningitidis, carry genes for anaerobic energy generation, consistent with the notion that anaerobic metabolism might have an important role in the survival and virulence of bacterial pathogens in the respiratory tract. Some of the genes encoding enzymes involved in anaerobic energy production in A. pleuropneumoniae have been shown to be essential for virulence. For example, knockout mutants of hlyX are unable to survive in lung epithelium, sequestered lungs or tonsils [29]; dmsA mutants are attenuated in acute disease [25]; and asp mutants cause less severe lung lesions than the wild type organism [24]. Similarly, in Bordetella pertussis, another respiratory tract pathogen, the FNR homolog, Btr [41] is essential for survival of this pathogen in mice [42]. The role of the nitrate-inducible energy metabolism genes, nap and nrf, is unknown in A. pleuropneumoniae. Nitrate metabolism has, however, been shown to be essential for the entry and replication of Salmonella Typhi in epithelial cells [43] and for the survival and virulence of Mycobacterium bovis in mice [44], [45]. In addition to the genes encoding enzymes of energy metabolism discussed above, the transcription of Na+ -translocating NADH-quinone reductase (NQR) was also enhanced in BALF (Table 3 and S1). NQR is a primary Na+ pump that translocates Na+ ions outside the cytoplasmic membrane to generate a sodium motive force, instead of a proton motive force, for energy production [46], [47]. The NQR enzyme is a complex of six subunits encoded by the nqrABCDEF operon [48], [49]; all six genes are present in all of the genomes of A. pleuropneumoniae reported to date. Another Na+-cycling gene, nhaB (an Na+/H+ antiporter), which, like NQR, could be involved in energy generation or in sodium homeostasis [46], was also up-regulated in BALF.
Table 3

BALF up-regulated virulence-associated genes reported in other studies.

GenesType of studyReference no.
bioD1, nhaB, apxIVA, rps, dmsA, hya SCOTS (acute infection; 7 days PI)) [22]
nqrB, dnaG, rpsT, rplL, rho, secA, truD, nusA, atpD, sap, rps, rpl SCOTS (chronic infection; 21 days PI) [23]
dmsA Knockout mutation [25]
nqr, hemA, napB, atp, ccm, recR, tonB, galU, cpxC, gloB Signature tagged mutagenesis (24 h PI) [51]
sec, nusG In vivo expression technology (12 and 16 h PI) [84]
exbB2, atp, dnaK Signature tagged mutagenesis (20 h PI) [85]
apxIVA, malF, malG, APL_0668 (predicted periplasmic lipoprotein involved in iron transport) In vivo transcript profiling of A. pleuropneumoniae by microarrayDeslandes (personal communication)

Complete gene names are given in Table S1.

Complete gene names are given in Table S1. In previous studies, the nqrB [23] and nhaB [22] genes and the NqrA (AopA) protein [50], which are all involved in Na+-cycling, have been reported to be up-regulated in A. pleuropneumoniae when it is grown in vivo. The importance of NQR, the major Na+-cycling enzyme, in survival and pathogenesis of A. pleuropneumoniae is unknown. However, BHI containing 2-n-nonyl-4-hydroxyquinoline N-oxide (HQNO), an inhibitor of NQR, does not allow growth of A. pleuropneumoniae CM5, while E. coli DH5α grows well in media containing HQNO (unpublished data). Further, in signature tagged mutagenesis studies, the nqrB gene was found to be essential for persistence A. pleuropneumoniae in the host [51]. Although genome sequencing has revealed that many bacterial pathogens possess homologues of nqr and other primary and secondary sodium pumps [46], the role of Na+ -cycling in pathogenesis is largely unknown, except in Vibrio cholerae. In V. cholerae, mutation of nqr results in increased expression of toxT, a positive regulator of virulence factors including cholera toxin and toxin co-regulated pilus [52], [53]. NQR is best known for its involvement in energy transduction, cytoplasmic pH regulation and ion homeostasis in marine and halophilic bacteria [54], [55]. Other BALF-up-regulated A. pleuropneumoniae genes encoding enzymes of energy metabolism included the heme exporter gene (ccmC), ATP synthase epsilon chain (atpC), deoxyribosephosphate aldolase (deoC) and 1-phosphofructokinase (fruK). The ccmC gene is a part of the ccmABCDEFGH operon which encodes proteins required for maturation of cytochrome C [56], an essential component of the electron-transfer chain [57]; whereas AtpC is a part of the F1 complex of ATP synthase [58]; DeoC cleaves deoxyribose 5-phosphate to acetaldehyde and glyceraldehyde 3-phosphate for central carbon metabolism [59]; and FruK regulates the flow of glucose through glycolysis [60]. Thus in BALF, A. pleuropneumoniae enhances transcription of the genes encoding both the central carbon metabolism and the energy transduction proteins. The down-regulation of genes encoding TCA cycle related enzymes, phosphoenolpyruvate carboxylase (pepC and succinylCoA ligase (ADP forming) subunit alpha (sucD) genes (Table S1) again points to the importance of anaerobic metabolism in A. pleuropneumoniae. Phophoenolpyruvate carboxylase catalyses carboxylation of pyruvate to oxaloacetate and succinyCOA ligase catalyzes the nucleotide-dependent conversion of succinyl-CoA to succinate [61], [62]. The genes encoding putative haloacid dehalogenase like hydrolase (pfhB) and xylose isomerase (xylA) were also down-regulated, which could be because of the absence of the substrates for these enzymes in BALF or because alternate pathways are preferable in that environment. Haloacid dehalogenase catalyzes dehalogenation of L-2-haloalkanoic acids to form D-2-hydroxyalkanoic acids [63] and xylose isomerase converts xylose to xylulose [64]. The xylose transport system permease gene (xylH) was also down-regulated in BALF as were the mannitol (PTS system mannitol-specific EIICBA component, mtlA) and ribose (D-ribose binding periplasmic protein precursor, rbsB) transport systems (Table S1) consistent with the absence of manitol and ribose in BALF or the presence of a preferred substrate. The ferritin-like protein 2 encoding-gene, ftnB, which is involved in protection against oxidative damage to iron-sulfur-containing enzymes such as the tricarboxylic acid (TCA) enzyme aconitase [65] was also down-regulated in BALF. Since A. pleuropneumoniae lacks aconitase, the target of FtnB is not obvious. This result nevertheless suggests that A. pleuropneumoniae is not under oxidative stress in BALF.

Modulation of gene expression for survival and virulence in BALF

Following incubation in BALF, A. pleuropneumoniae CM5 up-regulates genes required for cell wall synthesis, repair and recombination of DNA, and secretion and trafficking of ions and biomolecules (Table S1). Several genes encoding cell wall biosynthesis proteins were up-regulated in BALF, including those required for synthesis of peptidoglycan, LPS and integral membrane proteins (Table S1). Up-regulated genes for peptidoglycan biosynthesis enzymes included phosphoglucosamine mutase (mrsA), alanine racemase (alr), and D-alanyl D-alanine carboxypeptidase fraction A (dacA). MrsA converts glucosamine-6-phosphate to glucosamine-1-phophate which finally yields UDP-N-acetyl glucosamine for both peptidoglycan and LPS biosynthesis [66]–[68] while Alr catalyses the isomerization of L-alanine into D-alanine which is essential in bacteria for peptidoglycan biosynthesis [66], [69], and DacA catalyzes transpeptidation between neighboring peptide chains of N-acetylmuramyl-N-acetylglucosyl polysaccharides to produce cross-links in the cell wall. DacA can also act as a carboxypeptidase to control the amount of cross-linking in peptidoglycan [70], [71]. A semi-rough LPS is present in A. pleuropneumoniae serotype 1 [72], and the BALF-up-regulated genes encoding LPS biosynthesis proteins included the tetraacyldisaccharide 4′kinase (LpxK) required for lipid-A biosynthesis, and a bifunctional protein (HldE) and UTPglucose-1-phosphate uridylyltransferase (GalU), required for LPS core biosynthesis. Genes encoding capsular export proteins, CpxA (ATP binding protein) and CpxC (capsule polysaccharide export inner membrane protein) were also up-regulated in BALF. While the genes encoding peptidoglycan and LPS biosynthesis proteins described above are assumed to be essential for the survival of A. pleuropneumoniae, a clear role for capsular polysaccharides in the virulence of the bacterium has been demonstrated [73], [74]. In addition to cell surface polysaccharides synthesis genes, the genes encoding the outer membrane protein OmpW (outer membrane protein W precursor) and a lipoprotein (outer membrane antigenic lipoprotein B precursor) were also up-regulated in BALF. The up-regulation of genes encoding proteins of cell wall biosynthesis may help the organism to overcome cell surface-damaging components present in BALF. Transcription of genes encoding proteins involved in replication, and recombination and repair was enhanced in BALF. Genes encoding subunits of DNA polymerase III, various recombination proteins of the RecF machine, and an exonuclease (uvrA of uvrABC) were all up-regulated in BALF. Replication and recombination are two intertwined processes [75]; enhancement of transcription of genes involved in these two processes is consistent with active replication of A. pleuropneumoniae in BALF. On the other hand, rec2, encoding recombination protein2 and involved in transport of DNA across the cell envelope in competent bacteria [76], was down-regulated in BALF as were 3 genes predicted to have transposon functions. The fact that the expression of transposases is reported to be associated with starvation and other stressful conditions is again consistent with BALF being a favorable environment for A. pleuropneumoniae [77]. For survival in the host, bacteria require nutrients for biosynthesis of various biomolecules. In BALF, A. pleuropneumoniae increased transcription of genes encoding proteins required for transport of various nutrients. For example, complex-carbohydrate transport genes malF and malG, involved in maltose and maltodextrin transport, were up-regulated in BALF. Similarly, Group A Streptococcus enhances transcription of genes encoding proteins required for maltodextrin uptake in saliva and ΔmalE:malT strains are attenuated in their growth and in their ability to catabolize α-glucans [78]. Genes for amino acid (9) and nucleotide (3) biosynthesis were down-regulated suggesting that some or all amino acids and nucleotides were either directly or indirectly, available in BALF. Consistent with this finding, amino acid transporters such as BrnQ (for branched chain amino acid) and SdaC (for serine transport) were up-regulated. In contrast, the product of the glycerol uptake facilitator gene, glpF, which allows transport of glycerol, erythritol, pentitols, and hexitol,was down-regulated, however, this gene is known to be down-regulated presence of glucose [79]. In BALF, A. pleuropneumoniae also increased transcription of genes encoding proteins required for transport of iron and potassium. Genes encoding the cell membrane transport proteins, ExbD and ExbD2, and FbpB (iron (III) ABC transporter, ATP-binding protein), which are involved in energy-coupled transport of the iron-containing compound, transferrin were up-regulated in BALF, as was fieF. The cation efflux pump, FieF, probably protects the bacterium from ferrous iron toxicity [80]. The gene encoding PtsN (PTS system, nitrogen regulatory IIA like protein) was also up-regulated in BALF. PtsN has recently been shown to regulate transport of K+ through its interaction with a K+ transporter in E. coli and could be involved in ion homeostasis needed for optimal survival of A. pleuropneumoniae in BALF [81]. Incubation in BALF also led to increased expression of A. pleuropneumoniae CM5 genes encoding toxin synthesis and antimicrobial-resistance compounds. The ApxIV RTX toxin is reported to be expressed only in vivo [82], [83]. Following exposure to BALF we have shown in vitro expression of apxIVA for the first time. ApxIVA is a homolog of FrpC in Neisseria meningitidis. FrpC is involved in tissue invasion of N. meningitidis [84]. The role, if any, of ApxIV in the pathogenesis of A. pleuropneumoniae, however, remains to be demonstrated. The sapF gene is a part of the sapABCDF operon was up-regulated in BALF. It is involved in resistance to antimicrobial peptides in Vibrio fischeri [85], and in non-typable Haemophilus influenzae [86]. Also, sapD mutants of non-typable H. influenzae have been shown to be attenuated in a chinchilla model of otitis media [87]. A. pleuropneumoniae possesses a complete sap operon, which could have significant role in the survival of the pathogen in the host. Another detoxification molecule, glyoxylase II (gloB) is an enzyme involved in conversion of dicarbonyl compounds to less reactive hydroxy acids [88] was also up-regulated. It has been shown to be essential for survival of A. pleuropneumoniae in vivo [51] likely by protecting the organism against harmful dicarbonyl compounds present in the host. Expression of the ostA gene was also enhanced in A. pleuropneumoniae CM5 after incubation in BALF. The role for OstA in A. pleuropneumoniae is not known at this time, but in Helicobacter pylori, OstA confers protection against organic solvents and antibiotics [89], and in E. coli, it is essential for survival and has a direct role in membrane biogenesis and effects the lipid:protein ratio of the cell membrane [90]. In N. meningitidis, OstA is required for LPS biosynthesis [90]. Transcription of secB, which is a part of the Sec machinery, was also enhanced in BALF. The Sec machinery plays a key role in the translocation of proteins across, and integration of some proteins into, the cytoplasmic membrane of bacteria [91]. In A. pleuropneumoniae, secA and secB, another protein of the Sec machinery, have been shown to be expressed in vivo during both acute and chronic infection [23], [92], [and 93]. Several genes encoding transcriptional regulators, protein stabilization and folding and transposon functions were down-regulated in BALF. The precise role of these down-regulated transcriptional regulators is unknown in A. pleuropneumoniae, but FadR (a member of the GntR family of regulators) is an activator of unsaturated fatty acid acid synthesis in E. coli, although the authors do note that the FadR regulon in other gammaprotobacteria such as Haemophilus influenzae is much smaller [94]. Nevertheless, it is reasonable to assume that fatty acids would be freely available in BALF and their synthesis would not be required [95]. MerR transcriptional regulators have similar N-terminal helix-turn-helix DNA binding regions and C-terminal effector binding regions specific to the effector. Most of these regulators respond to oxidative stress and the presence of heavy metals and antibiotics in the medium [96]. The down-regulation of a MerR transcriptional regulator is consistent with the absence of stressors in the medium. Similarly, the precise role of protein folding and stabilization proteins in A. pleuropneumoniae has not been reported, but in other systems, proteins such as HtpG and HtpX are usually up-regulated during stress such as nutrient deprivation and their down-regulation is consistent with BALF being a comparatively non-stressful environment [97], [98]. In the current study, genes encoding 22 “unclassified or unknown” proteins were up-regulated while genes encoding a further 19 “unclassified or unknown” proteins were down-regulated. This large set of gene encoding unknown proteins could have a significant role in the survival and pathogenesis of A. pleuropneumoniae. In the future, it may be possible to predict functions of unknown genes by using bioinformatic approaches such have been developed for analysis of human microarray data [99]. In summary, incubation in BALF appears to simulate in vivo conditions and may provide a useful medium for the discovery of novel vaccine or therapeutic targets. In this environment, A. pleuropneumoniae is actively involved in protein and cell envelope biosynthesis and in general, BALF appears to provide a comparatively favorable and nutrient replete environment. Although more than 40% of the genes that were up-regulated following a 30 min exposure to BALF had been reported in earlier in vivo studies (Table 3), we have described an additional 70 genes whose precise role in survival and virulence of A. pleuropneumoniae is unknown and merit further study.

Materials and Methods

Collectin and concentration of bronchoalveolar fluid (BALF)

BALF was obtained from ten specific pathogen free pigs, each weighing about 15 kg. The pigs were euthanized, and the lungs were lavaged in situ using a catheter passed through a bronchoscope to instill 100 ml of sterile PBS into the trachea. After ∼1 min, lung washings were collected and centrifuged to remove cell debris. The cell-free lavage was concentrated with a 5 kDa molecular weight cut off ultrafiltration device, Vivacell 70 (Vivascience Ltd., Stonehouse, Gloucestershire,UK). A total of about 100 ml of BALF was collected from each pig and concentrated to a final volume of 5 ml. Concentrated BALF from each pig was pooled and sterilized by passage through a 0.22 µm membrane filter. From collection to concentration, BALF was kept at 4°C; the concentrated BALF was stored at −80°C for long-term storage. Molecules less than 5 kDa in molecular weight were not concentrated by this method; nevertheless, the fluid still contained these substances in concentrations found before ultrafiltration and the concentrated BALF represents alveolar epithelial fluid better than unprocessed BALF. The procedure used for BALF collection received approval from the Animal Care Committee of the University of Guelph and was consistent with the Guidelines of the Canadian Council on Animal Care.

Assessment of bacterial survival in BALF

Exponential growth phase cultures of A. pleuropneumoniae CM5 and Escherichia coli DH5α were incubated in 2 ml of concentrated BALF at 37°C. As a control, bacteria were also incubated in phosphate-buffered saline (PBS). A 50-µl aliquot was taken from each of the cultures after 15 and 30 min of incubation in BALF and PBS and plated onto brain heart infusion (BHI; Becton, Dickinson and Company, Sparks, MD, USA) agar supplemented with 0.01% (wt/vol) β-nicotinamide adenine dinucleotide (NAD). The number of colony-forming units (CFU) was counted after incubation overnight at 37°C. The number of bacteria surviving in BALF at each time point was expressed as the percent of number of bacteria surviving in PBS. The data were analyzed using one-way analysis of variance (ANOVA); the means were compared using Tukey's method.

Culture conditions for identification of differentially expressed genes in BALF

The virulent A. pleuropneumoniae serotype 1 strain CM5 was grown in BHI (Becton, Dickinson and Company) broth supplemented with 0.01% (wt/vol) NAD, at 37°C to an OD600 of 0.7 (approximately 107 CFU/ml). The cell suspension was split into two equal parts and centrifuged at 10,000 xg for 1 min to pellet the cells. One pellet was suspended in pre-warmed concentrated BALF and the other in fresh pre-warmed BHI broth supplemented with NAD. The volume of BALF and BHI broth used to suspend the cell pellets was equal to that of the culture from which the pellets were obtained, so that the resulting cell suspension contained approximately 107 CFU/ml. The cell suspensions were incubated with constant agitation at 37°C for 30 min and harvested by centrifugation for RNA extraction.

RNA extraction

RNA was extracted using Trizol Reagent (Invitrogen, Carlsbad, CA, USA) according to the instructions of the manufacturer. RNA quantity and quality was determined using an RNA 6000 Nano LabChip read in a Bioanalyzer 2100 instrument (Agilent Technologies, Santa Clara, CA, USA). RNA was treated with Turbo DNA-free (Ambion, Austin, TX, USA) to remove traces of contaminating DNA. For hybridization in microarray experiments, RNA was extracted from 3 independent biological replicates.

Labeling of cDNA and microarray hybridizations

cDNA synthesis was carried out as described previously [100]. Briefly, RNA (15 µg per reaction) from target (BALF-incubated bacteria) and reference (BHI-incubated bacteria) samples was used to synthesize cDNA in the presence of amino-allyl-dUTP (Sigma-Aldrich, St. Louis MO, US), random octamer primers (Biocorps, Montreal, QC, Canada), and SuperScript II transcriptase (Invitrogen, Carlsbad, CA, US). cDNAs were labeled indirectly with mono-functional NHS-ester Cy3 or Cy5 dye (GE Healthcare, Buckinghamshire, UK) and the efficiency of the labeling reactions was determined spectrophotometrically. RNA from three independent biological replicates was used in the labeling reaction. Four hybridizations, including the dye-swap experiment, were carried out between the target and the reference samples. The microarray data from this study were submitted to the Gene Expression Omnibus repository at NCBI and assigned accession number GEO: GSE13006.

Microarray chip design

The AppChip2 microarray chip used in this study is an evolved version of the AppChip1 chip, and like its predecessor, was a part of the A. pleuropneumoniae 5b L20 genome sequencing project [101]. For construction of AppChip2, open-reading-frame (ORF) PCR fragments of 160-nucleotide length and above were spotted in duplicate on microarray slides. The spots represent 2033 ORFs, covering 95% of the total ORFs, from the complete genome sequence of the organism. Spotted sheared genomic DNA from A. pleuropneumoniae L20 and porcine DNA are used as controls (http://ibs-isb.nrc-cnrc.gc.ca/glycobiology/appchips_e.html). Other details concerning chip production are described elsewhere [102].

Microarray data analysis

Microarray image and data analysis were carried out using the TM4 Suite [103] of software. Briefly, images were analyzed with Spotfinder v3.1.1. Background intensity was subtracted from the integrated intensity of each spot, and the spots that were less than one standard deviation above background intensity were eliminated, as were ones with total intensity less than 10,000. Replicate spots were analyzed subsequent to LOWESS (locally weighted linear regression) normalization of the data. Genes that were represented by good quality spots on a minimum of three replicate slides were considered for downstream analysis using SAM (significance analysis of microarray) to identify differentially expressed genes. A median false discovery rate (FDR = expected rate of falsely identified up- or down-regulated genes [104]) of 1.07% was used to generate a list of differentially expressed genes, which were classified into various functional classes using the JCVI Comprehensive Microbial Resource [105] tool.

Quantitative real-time PCR

RNA capacity (the maximum RNA concentration that can be used without affecting efficiency of reverse transcription), optimum primer concentration (list of primers is given in Table S2), and gene dynamic ranges were determined before carrying out real-time PCR for relative quantification of target genes. Synthesis of template cDNA was carried out in a 20-µl reaction mixture containing 500 ng RNA, using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Streetsville, ON, Canada). SYBR-Green-dye-based real-time PCR methodology was carried out using MicroAmp Optical 96- well plates (Applied Biosystems) in a StepOnePlus thermocycler (Applied Biosystems) for relative quantification of target genes. The 20-µl PCR reaction mixtures contained 10 µl of 2× Power SYBR Green PCR Master Mix (Applied Biosystems), 100 nM of forward and reverse primer, and 5 µl of template cDNA. The real-time PCR thermal profile included heat-activation of AmpliTaq Gold DNA Polymerase at 95°C for 10 min, and three-step 40-cycle PCR of denaturation at 95°C for 15 sec, primer annealing and extension at 60°C for 1 min. The Comparative CT (or ΔΔ CT) method [106] where ΔΔ CT = (CT, target−CT, )BALF−(CT, target−CT, )BHI was used to determine the relative gene expression of the target genes in BALF. As an endogenous control, the level of prolyl-tRNA-synthetase gene expression was used to normalize target gene expression levels, since this gene exhibited the least variation in expression across various conditions in both the microarray and real-time PCR experiments. Three independent biological replicates were tested in triplicates in the PCR experiments for the relative quantification of target genes. (0.26 MB DOC) Click here for additional data file. (0.04 MB DOC) Click here for additional data file.
  104 in total

1.  Salmonella typhi mutants defective in anaerobic respiration are impaired in their ability to replicate within epithelial cells.

Authors:  Inés Contreras; Cecilia S Toro; Gonzalo Troncoso; Guido C Mora
Journal:  Microbiology (Reading)       Date:  1997-08       Impact factor: 2.777

2.  Identification of Btr-regulated genes using a titration assay. Search for a role for this transcriptional regulator in the growth and virulence of Bordetella pertussis.

Authors:  G E Wood; N Khelef; N Guiso; R L Friedman
Journal:  Gene       Date:  1998-03-16       Impact factor: 3.688

Review 3.  The F0F1-type ATP synthases of bacteria: structure and function of the F0 complex.

Authors:  G Deckers-Hebestreit; K Altendorf
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

4.  HlyX, the FNR homologue of Actinobacillus pleuropneumoniae, is a [4Fe-4S]-containing oxygen-responsive transcription regulator that anaerobically activates FNR-dependent class I promoters via an enhanced AR1 contact.

Authors:  J Green; M L Baldwin
Journal:  Mol Microbiol       Date:  1997-05       Impact factor: 3.501

Review 5.  Expression and functional properties of fumarate reductase.

Authors:  J J Van Hellemond; A G Tielens
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 6.  Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors.

Authors:  G Unden; J Bongaerts
Journal:  Biochim Biophys Acta       Date:  1997-07-04

7.  Characterization of the essential gene glmM encoding phosphoglucosamine mutase in Escherichia coli.

Authors:  D Mengin-Lecreulx; J van Heijenoort
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

8.  Molecular characterization of a common 48-kilodalton outer membrane protein of Actinobacillus pleuropneumoniae.

Authors:  W T Cruz; Y A Nedialkov; B J Thacker; M H Mulks
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

Review 9.  Nitrite and nitrate analyses: a clinical biochemistry perspective.

Authors:  G Ellis; I Adatia; M Yazdanpanah; S K Makela
Journal:  Clin Biochem       Date:  1998-06       Impact factor: 3.281

10.  Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs.

Authors:  G A Zeballos; R D Bernstein; C I Thompson; P R Forfia; N Seyedi; W Shen; P M Kaminiski; M S Wolin; T H Hintze
Journal:  Circulation       Date:  1995-06-15       Impact factor: 29.690

View more
  15 in total

1.  Transcriptional profiling of Actinobacillus pleuropneumoniae during the acute phase of a natural infection in pigs.

Authors:  Vincent Deslandes; Martine Denicourt; Christiane Girard; Josée Harel; John H E Nash; Mario Jacques
Journal:  BMC Genomics       Date:  2010-02-08       Impact factor: 3.969

2.  Predicting genetic traits and epitope analysis of apxIVA in Actinobacillus pleuropneumoniae.

Authors:  Min-Kyoung Shin; Seung-Bin Cha; Won-Jung Lee; Han Sang Yoo
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

Review 3.  Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host.

Authors:  Koen Chiers; Tine De Waele; Frank Pasmans; Richard Ducatelle; Freddy Haesebrouck
Journal:  Vet Res       Date:  2010-06-15       Impact factor: 3.683

4.  Changes in gene expression of Actinobacillus pleuropneumoniae in response to anaerobic stress reveal induction of central metabolism and biofilm formation.

Authors:  Lu Li; Jiawen Zhu; Kui Yang; Zhuofei Xu; Ziduo Liu; Rui Zhou
Journal:  J Microbiol       Date:  2014-04-11       Impact factor: 3.422

5.  Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae.

Authors:  Falk Fr Buettner; Sarah A Konze; Alexander Maas; Gerald F Gerlach
Journal:  Proteome Sci       Date:  2011-04-20       Impact factor: 2.480

6.  Global effects of catecholamines on Actinobacillus pleuropneumoniae gene expression.

Authors:  Lu Li; Zhuofei Xu; Yang Zhou; Lili Sun; Ziduo Liu; Huanchun Chen; Rui Zhou
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

7.  The comprehensive microbial resource.

Authors:  Tanja Davidsen; Erin Beck; Anuradha Ganapathy; Robert Montgomery; Nikhat Zafar; Qi Yang; Ramana Madupu; Phil Goetz; Kevin Galinsky; Owen White; Granger Sutton
Journal:  Nucleic Acids Res       Date:  2009-11-05       Impact factor: 16.971

8.  malT knockout mutation invokes a stringent type gene-expression profile in Actinobacillus pleuropneumoniae in bronchoalveolar fluid.

Authors:  Abdul G Lone; Vincent Deslandes; John H E Nash; Mario Jacques; Janet I MacInnes
Journal:  BMC Microbiol       Date:  2009-09-14       Impact factor: 3.605

9.  SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus.

Authors:  Andrew R Vogel; Blake R Szelestey; Forrest K Raffel; Samantha W Sharpe; Rachel L Gearinger; Sheryl S Justice; Kevin M Mason
Journal:  Front Cell Infect Microbiol       Date:  2012-04-03       Impact factor: 5.293

10.  Actinobacillus pleuropneumoniae genes expression in biofilms cultured under static conditions and in a drip-flow apparatus.

Authors:  Yannick D N Tremblay; Vincent Deslandes; Mario Jacques
Journal:  BMC Genomics       Date:  2013-05-31       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.